This study looks at a drug called lasmiditan, which is being tested to see if it's safe and works well for treating migraine headaches in children aged 6 to 17. A migraine is a type of headache that can cause bad pain and other symptoms like nausea. This study lasts about 12 months, and you might need to visit the study center up to 7 times. It's an open-label study, which means both you and the doctors know that you are getting lasmiditan.

Eligibility:

• You must have finished another study before joining this one.
• You need to weigh at least 15 kilograms (about 33 pounds).

Things to Consider:

• The study lasts 12 months with up to 7 visits.
• This study is testing a medicine for migraines, so you must have migraines to join.
• If you are pregnant or have serious health issues, you can't join.

Before deciding to join, consider the time commitment and if you meet the eligibility requirements.